Muriel Mac-Seing
ID: UNCST-2024-R005208
|
The Together Project 2.0: Co-creation and co-evaluation of accessible and gender-sensitive sexual and reproductive health and rights education video series for and with youth in situations of vulnerability in Uganda and Bangladesh
REFNo: SS3812ES
1. To identify SRHR education gaps and needs for youth in situations of vulnerability with limited to no access to SRHR education programs, in Gulu, Uganda, and Dhaka, Bangladesh (Phase 1)
2. To co-develop with youth in situations of vulnerability inclusive SRHR education programs that are contextually adapted to their needs and realities, while considering accessibility, social acceptability, and available SRHR resources (Phase 2).
3. To co-evaluate the relevance of the co-developed SRHR education content and co-learn for improved adaptation through community feedback-seeking and to inform further dissemination strategies tailored to the specific needs and preferences of youth in Gulu, Uganda, and Dhaka, Bangladesh (Phase 3).
|
Canada |
2025-04-30 17:51:45 |
2028-04-30 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
SSENYONJO TADDEO BIRUNGI
ID: UNCST-2024-R002326
|
EFFECT OF CLIMATE CHANGE ON THE SOCIO-ECONOMIC CONDITION OF SUBSISTENCE CATTLE FARMERS IN NAKASONGOLA DISTRICT,UGANDA.
REFNo: A593ES
1.3 Objectives of the Study
1.3.1 Major objective
To examine the effects of climate change on the socio- economic condition of subsistence cattle farmers in Nakasongola district and propose an appropriate farmer adaptation strategy.
1.3.2 Specific objectives
1.To describe negative effects of climate change faced by subsistence cattle farmers in Nakasongola District.
2.To explore impact of climate change on the socio-economic conditions of subsistence cattle farmers in Nakasongola District.
3. To evaluate adaptation and coping practices of subsistence cattle farmers in Nakasongola District with the effects of climate change.
4.To develop an adaptation strategy to the effects of climate change relevant to subsistence cattle farmers in Nakasongola District.
|
Uganda |
2025-04-30 17:47:19 |
2028-04-30 |
Agricultural Sciences |
Non-Clinical Trial |
Degree Award |
|
Isaac Ssewanyana
ID: UNCST-2020-R014336
|
KHB HIV I/II Ab RAPID TEST (REF: R-429-1-C-1 and REF: R-429-50-C-1 ): Part of the Diagnostic Sensitivity and Diagnostic Specificity
REFNo: HS5945ES
The objective of this evaluation is twofold. By collecting capillary whole blood (i.e. fingerprick) samples and corresponding venous whole blood (EDTA-K2) and plasma (EDTA-K2) samples the following objectives are assessed:
1) To establish the performance of the KHB HIV I/II Ab RAPID TEST using capillary whole blood or fingerprick samples when performed by lab technicians at an African hospital lab and by lay providers/healthcare workers (Nurses, Counsellors, clinical officers) at an African rural hospital lab.
2) To demonstrate specimen equivalence between capillary whole blood, venous whole blood and plasma.
This study will be conducted according to WHO TSS-1; Part 1 and part 2: Establishing clinical performance characteristics (professional use and/or self-testing.
|
Uganda |
2025-04-28 12:28:00 |
2028-04-28 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Justine Komunyena Tumusiime
ID: UNCST-2023-R008465
|
Assessment of the Country-Level Implementation and Use of Vaccine-Preventable Disease Surveillance Information Systems in the WHO African Region
REFNo: HS5798ES
To assess the current landscape of VPD surveillance systems across the 47 WHO AFRO member states, with a focus on system type, dreadiness, integration with broader health information systems, and identification of key gaps, needs, and opportunitiesigital ,
|
Uganda |
2025-04-28 12:19:35 |
2028-04-28 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Victoria Nankabirwa
ID: UNCST-2021-R011871
|
A Case Control Study to Assess Effectiveness and Safety of the R21/Matrix
M Malaria Vaccine.
REFNo: HS5891ES
1) To assess the Vaccine Effectiveness (VE) of R21/Matrix-M vaccine against
severe malaria caused by Plasmodium falciparum.
2) To assess the Vaccine Effectiveness (VE) of R21/Matrix-M vaccine against
clinical malaria caused by Plasmodium falciparum in high-transmission
perennial areas.
3) To assess if the R21/Matrix-M vaccine recipients are at an increased risk of
death (all-cause).
|
Uganda |
2025-04-25 9:46:49 |
2028-04-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|